Properties
What is it?
Mounjaro ® Solution for Injection 15mg/0.6mL 4 Doses Pen Composition: 15 mg/0.6 mL multi-dose pre-filled pen Mounjaro (tirzepatide) is a prescription medication for adults with type 2 diabetes used to improve blood sugar (glucose) control. The medicine is also used to treat adults with obesity or overweight (BMI of 27 kg/m² or greater) who have weight-related health problems (e.g., prediabetes, type 2 diabetes, high blood pressure, abnormal blood lipid levels, etc.) It contains tirzepatide, a dual GIP and GLP-1 receptor agonist, belonging to a new class of medications called incretin mimetics. Each pen contains four fixed doses of the specified strength, meaning for example: A 15 mg pen contains a total of 60 mg of tirzepatide (4 doses x 15 mg), each at 0.6 mL. Patients inject one dose weekly, so each pen is designed for one month of use. How Mounjaro Works: Mounjaro is the first GIP and GLP-1 receptor agonist that works on glucose-dependent insulinotropic polypeptide (GIP) receptors and glucagon-like peptide-1 (GLP-1) receptors. Mounjaro lowers blood sugar levels, helps the pancreas produce more insulin, reduces the amount of sugar produced by the liver, and slows down the rate at which food leaves the stomach. This helps prolong the feeling of fullness and can reduce the amount of food consumed. All of this helps to keep blood sugar levels stable throughout the day. Mounjaro Side Effects: The most common side effects of Mounjaro include: nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion, and abdominal pain, affecting 5% or more of patients. Stop using this medication and get emergency medical help if you have: signs of an allergic reaction: hives; difficulty breathing; Call your doctor if you have: severe stomach problems; gallbladder problems with symptoms, stomach pain after eating, kidney problems with little or no urination, swelling in your ankles, feeling tired or short of breath. This is not a complete list of side effects and others may occur. Call your doctor about side effects. You should not use this medicine if you have or have a family history of a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called multiple endocrine neoplasia syndrome type 2. You should not use this medicine if: you are allergic to tirzepatide; you have a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2. Tell your doctor if you have ever had: pancreas problems; kidney disease; pregnancy: Tell your doctor if you are pregnant or plan to become pregnant while using this medication. This medication can make birth control pills less effective. How to Use Mounjaro: Inject once weekly into the abdomen, thigh, or upper arm at any time of day. Always try to use it on the same day of the week. Remember: Each pen contains four doses of the specified strength* One dose per week means one pen is a one-month supply. Mounjaro Dosing Information: Usual dose for adults with type 2 diabetes: Starting dose: 2.5 mg subcutaneous (under the skin) once weekly. After 4 weeks: The dose should be increased to 5 mg subcutaneous once weekly. If additional glycemic control is needed: The dose should be increased by 2.5 mg increments after at least 4 weeks on the current dose. Maximum dose: 15 mg subcutaneous once weekly. If needed, your doctor may increase your dose by 2.5 mg to 7.5 mg, 10 mg, 12.5 mg, or 15 mg once weekly. Do not change your dose unless your doctor tells you to. Storage Conditions: Unused pen syringes are stored in the refrigerator at 2°C to 8°C (do not store in the freezer). An unopened pen, if stored in the refrigerator, is good to use until the expiration date. Storage conditions after starting the use of the pen syringe: You can store it at room temperature (up to 30°C) for up to 30 days. Keep away from heat and sunlight. Discard after 30 days from the first use, even if there is still medicine left. Always use Mounjaro under the supervision of a doctor.